GUTS
FRACTYL HEALTH, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.38
−10.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -10.99x
- Price / sales
- —
- Price / cash flow
- -0.22x
Enterprise value
- Enterprise value
- $31.9M
- EV / sales
- —
- EV / EBITDA
- -0.31x
- EV / EBIT
- -0.37x
- Market cap
- $18.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026